Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.

Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR; PROGEMUS Group; PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S.

PLoS One. 2013 Jun 13;8(6):e64408. doi: 10.1371/journal.pone.0064408. Print 2013.

2.

Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH; International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF.

PLoS One. 2013;8(3):e58352. doi: 10.1371/journal.pone.0058352. Epub 2013 Mar 5.

3.

Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort.

Romero-Pinel L, Martínez-Yélamos S, Bau L, Matas E, Gubieras L, María Pujal J, Morandeira F, Bas J, Arbizu T.

Eur J Neurol. 2011 Oct;18(10):1258-62. doi: 10.1111/j.1468-1331.2011.03379.x. Epub 2011 Mar 21.

PMID:
21418440
4.

Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.

Balnytė R, Rastenytė D, Vaitkus A, Skrodenienė E, Vitkauskienė A, Ulozienė I.

Medicina (Kaunas). 2016;52(4):217-222. doi: 10.1016/j.medici.2016.07.004. Epub 2016 Jul 28.

5.

The significance of HLA DRB1*1501 and oligoclonal bands in multiple sclerosis: clinical features and disability.

Balnytė R, Rastenytė D, Ulozienė I, Mickevičienė D, Skordenienė E, Vitkauskienė A.

Medicina (Kaunas). 2011;47(7):368-73.

6.

Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.

Karrenbauer VD, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K.

J Neuroimmunol. 2013 Jan 15;254(1-2):170-3. doi: 10.1016/j.jneuroim.2012.08.011. Epub 2012 Sep 8.

PMID:
22967351
7.

Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.

Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

J Neurol Sci. 2010 Jan 15;288(1-2):63-7. doi: 10.1016/j.jns.2009.10.005. Epub 2009 Oct 30.

PMID:
19879597
8.

Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.

Niino M, Sato S, Fukazawa T, Yoshimura S, Hisahara S, Matsushita T, Isobe N, Yoshida K, Houzen H, Miyazaki Y, Shimohama S, Kikuchi S, Kira J.

Mult Scler. 2015 Aug;21(9):1112-20. doi: 10.1177/1352458514560924. Epub 2015 Jan 12.

PMID:
25583844
9.

HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.

Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, Hamada T, Hashimoto SA, Tashiro K.

Neurology. 2003 Feb 25;60(4):647-51.

PMID:
12601107
10.

Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA.

Mult Scler. 2014 May;20(6):660-8. doi: 10.1177/1352458513506503. Epub 2013 Oct 7.

11.

HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.

Imrell K, Greiner E, Hillert J, Masterman T.

J Neuroimmunol. 2009 May 29;210(1-2):128-30. doi: 10.1016/j.jneuroim.2009.03.005. Epub 2009 Mar 26.

PMID:
19327846
12.

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA; International Multiple Sclerosis Genetics Consortium, Sawcer SJ, Andreassen BK, Dubois B, Harbo HF.

Brain. 2015 Mar;138(Pt 3):632-43. doi: 10.1093/brain/awu405. Epub 2015 Jan 22.

13.

The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.

Idiman E, Ozakbas S, Dogan Y, Kosehasanogullari G.

J Neuroimmunol. 2009 Jul 25;212(1-2):121-4. doi: 10.1016/j.jneuroim.2009.04.014. Epub 2009 May 19.

PMID:
19457560
14.

Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.

Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A, Benedetti MD, Facchiano F, Monaco S, Calabrese M.

J Neuroinflammation. 2017 Feb 21;14(1):40. doi: 10.1186/s12974-017-0812-y.

15.

The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.

Balnyte R, Rastenyte D, Vaitkus A, Mickeviciene D, Skrodeniene E, Vitkauskiene A, Uloziene I.

BMC Neurol. 2013 Jul 9;13:77. doi: 10.1186/1471-2377-13-77.

16.

Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.

Imrell K, Landtblom AM, Hillert J, Masterman T.

Neurology. 2006 Sep 26;67(6):1062-4.

PMID:
17000979
17.

Similar familial risk in multiple sclerosis subgroups.

Song J, Karrenbauer V, Manouchehrinia A, Almqvist C, Hillert J, Westerlind H.

Mult Scler. 2017 Nov;23(13):1782-1785. doi: 10.1177/1352458516684214. Epub 2017 Jan 16.

PMID:
28090800
18.

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.

da Gama PD, Machado Ldos R, Livramento JA, Gomes HR, Adoni T, Morales Rde R, da Gama RA, da Gama DA, Lana-Peixoto MA, Fragoso YD, Callegaro D.

Biomed Res Int. 2015;2015:217961. doi: 10.1155/2015/217961. Epub 2015 Jul 29.

19.

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.

Dobson R, Ramagopalan S, Davis A, Giovannoni G.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):909-14. doi: 10.1136/jnnp-2012-304695. Epub 2013 Feb 21. Review.

PMID:
23431079
20.

Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.

Anagnostouli M, Christidi F, Zalonis I, Nikolaou C, Lyrakos D, Triantafyllou N, Evdokimidis I, Kilidireas C.

Neurol Sci. 2015 Nov;36(11):2053-60. doi: 10.1007/s10072-015-2303-1. Epub 2015 Jul 1.

PMID:
26130146

Supplemental Content

Support Center